4//SEC Filing
BENTLEY PHARMACEUTICALS INC 4
Accession 0000821616-04-000001
CIK 0000821616operating
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 3:00 PM ET
Size
22.8 KB
Accession
0000821616-04-000001
Insider Transaction Report
Form 4
MCGOVERN MICHAEL
Director10% Owner
Transactions
- Award
Right to purchase
2003-12-31+25,000→ 25,000 totalExercise: $13.47Exp: 2013-12-31→ Common Stock, $.02 par value (25,000 underlying)
Holdings
- 69,200
Right to purchase
Exercise: $6.00Exp: 2011-05-09→ Common Stock, $.02 par value (69,200 underlying) - 40,000
Right to purchase
Exercise: $9.15Exp: 2013-03-21→ Common Stock, $.02 par value (40,000 underlying) - 50,000
Right to purchase
Exercise: $9.80Exp: 2012-02-12→ Common Stock, $.02 par value (50,000 underlying) - 2,649,228
Common Stock, $.02 par value
- 30,000
Right to purchase
Exercise: $11.71Exp: 2012-05-22→ Common Stock, $.02 par value (30,000 underlying) - 70,000
Right to purchase
Exercise: $10.04Exp: 2013-05-21→ Common Stock, $.02 par value (70,000 underlying) - 25,000
Right to purchase
Exercise: $9.00Exp: 2010-04-01→ Common Stock, $.02 par value (25,000 underlying)
Footnotes (12)
- [F1]Options were granted under terms of the Company's 1991 Stock Option Plan as remuneration for services as a member of the Board of Directors and/or Vice Chairman. Grant became exercisable on 4/1/2001.
- [F10]Options were granted under terms of the Company's 2001 Directors' Stock Option Plan as remuneration for services as a member of the Board of Directors and/or Vice Chairman. Grant becomes exercisable in two equal installments on 3/21/2004 and 3/21/2005.
- [F11]Options were granted under terms of the Company's 2001 Directors' Stock Option Plan as remuneration for services as a member of the Board of Directors and/or Vice Chairman. Grant becomes exercisable in four equal installments on 7/31/2003, 10/31/2003, 1/31/2004 and 4/30/2004.
- [F12]Options were granted under terms of the Company's 2001 Directors' Stock Option Plan as remuneration for services as a member of the Board of Directors and/or Vice Chairman. Grant becomes exercisable on 4/30/2004.
- [F2]Options were granted under terms of the Company's 1991 Stock Option Plan as remuneration for services as a member of the Board of Directors and/or Vice Chairman. Grant became exercisable on 7/1/2001.
- [F3]Options were granted under terms of the Company's 1991 Stock Option Plan as remuneration for services as a member of the Board of Directors and/or Vice Chairman. Grant became exercisable on 10/1/2001.
- [F4]Options were granted under terms of the Company's 2001 Directors' Stock Option Plan as remuneration for services as a member of the Board of Directors and/or Vice Chairman. Grant became exercisable on 5/9/2002.
- [F5]Options were granted under terms of the Company's 2001 Directors' Stock Option Plan as remuneration for services as a member of the Board of Directors and/or Vice Chairman. Grant became exercisable on 7/1/2002.
- [F6]Options were granted under terms of the Company's 2001 Directors' Stock Option Plan as remuneration for services as a member of the Board of Directors and/or Vice Chairman. Grant became exercisable on 8/30/2002.
- [F7]Options were granted under terms of the Company's 2001 Directors' Stock Option Plan as remuneration for services as a member of the Board of Directors and/or Vice Chairman. Grant becomes exercisable in two equal installments on 2/12/2003 and 2/12/2004.
- [F8]Options were granted under terms of the Company's 2001 Directors' Stock Option Plan as remuneration for services as a member of the Board of Directors and/or Vice Chairman. Grant becomes exercisable in two equal installments on 5/22/2003 and 5/22/2004.
- [F9]Options were granted under terms of the Company's 2001 Directors' Stock Option Plan as remuneration for services as a member of the Board of Directors and/or Vice Chairman. Grant becomes exercisable in two equal installments on 6/21/2003 and 6/21/2004.
Documents
Issuer
BENTLEY PHARMACEUTICALS INC
CIK 0000821616
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000821616
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 3:00 PM ET
- Size
- 22.8 KB